[Experience with clarithromycin in pediatric patients].
Clarithromycin (TE-031, A-56268), a newly synthesized macrolide antibiotic, was administered to children and its efficacy was examined. The clinical efficacy rate of TE-031 was 88.5% in 26 patients with pediatric infections. This rate was regarded as quite high. A side effect, transaminase elevation, was observed in 1 out of the 26 patients but it was subsided after a cessation of the antibiotic treatment. TE-031 was considered to be effective antibiotic for the infectious disease in the pediatric fields because of highly efficacy rate.